National guidelines for malaria treatment in Democratic Republic of the Congo: A critical appraisal

Author:

Nkoli Papy Mandoko1,Moke Destin Mbongi2,Kisita Christelle1,Kambala Jean Pierre Mukendi1,Kahunu Gauthier Mesia3,Tshala-Katumbay Desiré1,Ngoyi Dieudonné Mumba1

Affiliation:

1. National Institute of Biomedical Research (INRB), Democratic Republic of the Congo

2. Training and Health Support Center (CEFA)/ Monkole Hospital Center

3. Unit of Clinical Pharmacology and Pharmacovigilance, Faculty of Medicine and Faculty of Pharmaceutical Sciences, University of Kinshasa, Democratic Republic of Congo

Abstract

AbstractCONTEXT AND OBJECTIVESThe fight against malaria is threatened by the emergence and expansion ofPlasmodium falciparumresistance to antimalarial drugs, to the point of questioning treatment patterns drawn by control programs. The objective of this work was to do a critical appraisal of the national guidelines for the treatment of malaria in the Democratic Republic of the Congo.METHODSTo estimate the selective pressure that leads to the emergence ofP. falciparumresistance to antimalarials, a cross-sectional survey was conducted on antimalarials in circulation in pharmacies in Kinshasa. Anex vivoevaluation of theP. falciparumresistance to antimalarial drugs and the analysis of molecular markers of Sulfadoxine-pyrimethamine resistance were conducted in the provinces of Kinshasa and Kongo Central during 2014 and 2015.RESULTS.The following antimalarial drugs were found in 404 pharmacies: Artemisinin-based combination therapies 88.1%, quinine 80.9%, Sulfadoxine-Pyrimethamine 56.4%, oral artemisinin-based monotherapies 23.0% and traditional medicine 30.2%. Artemether-lumefantrine combinations were the most frequently dispensed drugs (93% of pharmacies). The decrease in the susceptibility ofP. falciparumisolates to antimalarials was as follows: chloroquine 65.7%, quinine 52.6%, monodesethylamodiaquine 25%, mefloquine ~ 45%, dihydroartemisinin 1.3%, piperaquine 1.6%, and doxycycline 4.3%. No isolates were found to be lumefantrine-resistant. The prevalence of mutations was high inpfdhfr(N51I: 98.5%, C59R: 88.2%, and S108N: 99.4%) andpfdhps(A437G: 97.8%). ThepfdhpsA581G,pfdhpsK540E,pfdhfrI164L, andpfdhpsA613S mutations were 14%, 17.5%, 0.1%, and 0.6%, respectively.CONCLUSIONThese findings show a highex vivoresistance ofP. falciparumto quinine, the antimalarial that plays an important role in the fight against malaria in the DRC. The present work highlights the complexity of the inappropriate antimalarials distribution. This shows the lack of regulation in the distribution system, potentially affecting the dynamics of resistance.

Publisher

Research Square Platform LLC

Reference44 articles.

1. World health Organization. Guidelines for the treatment of malaria-3rd Edition.2015.

2. Tracking Resistance to Artemisinin Collaboration (TRAC).Spread of artemisinin resistance in Plasmodium falciparum malaria.N Engl;Ashley EA;J Med

3. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria;Ariey F;Nature,2014

4. Evidence of artemisinin- resistant malaria in western Cambodia;Noedl H;N Engl J Med,2008

5. Advances in understanding the genetic 350 basis of antimalarial drug resistance;Ekland EH;Curr Opin Microbiol,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3